Stock listing

Munich:DC4 DexCom, Inc. Aktie

German listing (Munich) of DexCom, Inc. · home listing NASDAQ:DXCM

Follow DexCom, Inc. into a list and get an email when it puts out news.

Share price · MUN:DC4

€70.40 EUR +0.60 (+0.9%)

Close on Oct 27, 2026

Day range
€70.40 – €70.40 EUROct 27, 2026
Market cap
€43.77B EURAt the close on Oct 27, 2026 · price × 621.7M shares outstanding
DexCom, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:DXCM · Home$82.29 USD+2.36 (+3.0%)8,637,191$81.52$85.25$79.79$79.93Close on Oct 30, 2026
B3:D1EX348.39 BRL+0.59 (+7.6%)518.338.518.337.80Close on Oct 27, 2026
Frankfurt:DC4€73.40 EUR+3.00 (+4.3%)—€72.40€75.20€72.40€70.40Close on Oct 30, 2026
Munich:DC4€70.40 EUR+0.60 (+0.9%)—€70.40€70.40€70.40€69.80Close on Oct 27, 2026
Ticker
Munich:DC4
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Munich
Currency
EUR

What changed lately

Calls

Replays

  • DexCom (NASDAQ:DXCM) Q3 2026 Earnings Call

    Thu, Oct 29, 2026 · 4:30 PM ET

    Watch Transcript

  • DexCom (NASDAQ:DXCM) Q2 2026 Earnings Call

    Thu, Jul 30, 2026 · 4:30 PM ET

    Watch Transcript

  • DexCom (NASDAQ:DXCM) Q1 2026 Earnings Call

    Thu, Apr 30, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Dexcom Reports Third Quarter 2026 Financial Results

Oct 29, 2026

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November

Oct 28, 2026

Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin

Oct 14, 2026

Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4: 30 p.m. Eastern Time

Oct 7, 2026

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

Oct 6, 2026

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

Sep 28, 2026

Dexcom Promotes Jereme Sylvain to Chief Operating Officer

Sep 14, 2026

Dexcom Appoints Glenn Boehnlein to Board of Directors

Sep 10, 2026

Dexcom Reports Second Quarter 2026 Financial Results

Jul 30, 2026

Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program

Jul 22, 2026

All DexCom, Inc. news

Decks

DexCom, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
39 in the last 12 months · 211 in all · newest Oct 29, 2026 · oldest 2019
Calls
32 calls with a replay · 32 with a transcript · latest Oct 29, 2026
Decks
30 decks · latest Oct 29, 2026

Where DexCom, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:DXCM · Home listingNASDAQUnited StatesUSD
gettex:DC4gettexGermanyEUR
LS Exchange:A0D9T1LS ExchangeGermanyEUR
Tradegate:DC4TradegateGermanyEUR
BMV:DXCMBMVMexicoMXN
Lang & Schwarz:A0D9T1Lang & SchwarzGermanyEUR
Dusseldorf:DC4DusseldorfGermanyEUR
B3:D1EX34B3BrazilBRL
Frankfurt:DC4FrankfurtGermanyEUR
BOATS:DXCMBOATSUnited StatesUSD
Milan:1DXCMMilanItalyEUR
LSE:0A4MLSEUnited KingdomUSD
Munich:DC4 · This pageMunichGermanyEUR
VIE:DXCMViennaAustriaEUR
Hanover:DC4HanoverGermanyEUR
Hamburg:DC4HamburgGermanyEUR
Stuttgart:DC4StuttgartGermanyEUR
Turquoise:DXCMNTurquoiseUnited KingdomUSD
BIVA:DXCMBIVAMexicoMXN
BX Swiss:DC4BX SwissSwitzerlandCHF
SIX Swiss:DXCMSIX SwissSwitzerlandCHF
SIX Swiss:DXCM.USDSIX SwissSwitzerlandUSD
Xetra:DC4XetraGermanyEUR

Log in to ask 6ix AI your own questions about DexCom, Inc.